Bisoprolol fumarate
Bisoprolol fumarate
CLINICAL USE
Beta-1 adrenoceptor blocker:cinHypertension, angina
Adjunctive treatment for heart failure DOSE IN NORMAL RENAL FUNCTION
5–20 mg dailyHeart failure: 1.25 mg daily increasing to 10 mg daily PHARMACOKINETICS
Molecular weight                           :767 %Protein binding                           :30 %Excreted unchanged in urine     : 50 Volume of distribution (L/kg)       :3.5half-life – normal/ESRD (hrs)      :9–12/18–24 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in normal renal function HD                     :Not dialysed. Dose as in normal renal function HDF/high flux   :Unknown dialysability. Dose as in normal renal functionCAV/VVHD      :Unknown dialysability. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAnaesthetics: enhanced hypotensive effect Analgesics: NSAIDs antagonise hypotensive effectAnti-arrhythmics: increased risk of myocardial depression and bradycardia; increased risk of bradycardia, myocardial depression and AV block with amiodaroneAntibacterials: concentration reduced by rifampicinAntidepressants: enhanced hypotensive effect with MAOIsAntihypertensives: enhanced hypotensive effect; increased risk of withdrawal hypertension with clonidine; increased risk of first dose hypotensive effect with post-synaptic alpha-blockers such as prazosinAntimalarials: increased risk of bradycardia with mefloquineAntipsychotics: enhanced hypotensive effect with phenothiazinesCalcium-channel blockers: increased risk of bradycardia and AV block with diltiazem; hypotension and heart failure possible with nifedipine and nisoldipine; asystole, severe hypotension and heart failure with verapamilDiuretics: enhanced hypotensive effect Moxisylyte: possible severe postural hypotensionSympathomimetics: severe hypertension with adrenaline and noradrenaline, and possibly with dobutamine ADMINISTRATION
Reconstition
– Route
Oral Rate of Administration
–Comments
– OTHER INFORMATION
Use with caution in patients with chronic obstructive airways disease, asthma or diabetes
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home